Introduction {#sec1_1}
============

Iron deficiency anemia (IDA) arises when the balance of iron intake, iron storage, and the body\'s loss of iron are insufficient to fully support the production of erythrocytes. IDA rarely causes death, but the impact on human health is significant \[[@B1]\]. Symptoms of IDA are related to decreased oxygen delivery to the entire body and may include the following: unexplained fatigue or lack of energy; shortness of breath or chest pain, especially with activity; unexplained generalized weakness; a rapid heartbeat; headache, especially with activity; craving for ice or clay ("picophagia"); a sore or smooth tongue; and brittle nails or hair loss \[[@B2]\]. According to the WHO, the criterion for anemia is a hemoglobin level \<13 g/dL in adult males and \<12 g/dL in adult females. As the iron deficiency worsens, both hemoglobin and PCV decline together \[[@B3]\]. The diagnosis of iron deficiency to be confirmed by any one of the following findings in the appropriate clinical setting: serum ferritin \<30 ng/mL; transferrin saturation \<19%, mostly used in patients for whom the ferritin level is thought to be unreliable due to an inflammatory state; or anemia that resolves upon iron administration or absence of stainable iron in the bone marrow (provided that adequate staining controls are performed \[[@B4]\]).

IDA presents with thrombocytosis; however, there rarely is an association between IDA and lymphocytopenia. Here, we would like to shed light on this rare presentation.

Case Presentation {#sec1_2}
=================

A 17-year-old female who presented with dizziness and fatigability was found to have severe anemia (hemoglobin 5.2 g/dL; normal value 12--15). Her menstrual cycle was normal, but she had poor nutrition; she denied other symptoms. On examination, she showed severe pallor, but no hepatosplenomegaly. For her laboratory results, see Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}.

Peripheral Smear {#sec2_1}
----------------

Red blood cells showed mild anisopoikilocytosis with few ovalocytes/elliptocytes and occasionally schistocytes. Leukocytes occasionally showed reactive lymphocytes. Monocytes were slightly prominent. Platelets were adequate.

The patient received IV ferric carboxymaltose (Ferinject) at 1,000 mg in 2 doses. Her symptoms, anemia, and lymphocytopenia dramatically improved after therapy.

Discussion {#sec1_3}
==========

Iron plays an essential role in immunosurveillance, because of its growth-promoting and differentiation-inducing properties for immune cells and its interference with cell-mediated immune effector pathways and cytokine activities \[[@B5]\].

IDA is a problem of serious public health significance that impacts mental and physical development, health maintenance, and work performance. It is the most common micronutrient deficiency worldwide. It exceeds 50% in developing countries and is usually attributed to inadequate nutrition \[[@B6]\]. IDA due to nutritional deficiency is not just a disease of developing countries, but it can also be seen in developed countries. Worldwide, over 40% of cases of children who have iron deficiency anemia are frequently associated with infections \[[@B7]\].

IDA impairs thyroid metabolism in animals and humans and may negatively affect the growth and development of children. On the other hand, both overt and subclinical hypothyroidism are associated with anemia, and adding iron to thyroxine therapy improves both conditions compared to thyroxine therapy alone. In addition, patients with chronic hemolytic anemia requiring repeated blood transfusion have a high prevalence of hypothalamic-pituitary-thyroid axis disturbances. Both primary hypothyroidism and central hypothyroidism occur in these patients with increasing prevalence with age and severity of the anemia \[[@B8]\]. It appears that all forms of chronic anemia have a negative effect on linear growth during all stages of growth (infancy, childhood, and adolescence). Although infants with chronic IDA may have delayed cognitive, motor, and affective functions \[[@B9]\], the effects on male fertility explored by Soliman et al. \[[@B10]\] in a study showed that correction of IDA with IV iron is associated with significant enhancement of sperm parameters and increased concentrations of serum LH, FSH, and T. These effects on spermatogenesis are reached by an unknown mechanism and suggest a number of pathways that need further human and/or experimental studies. In another study looking for the effects of IDA on glucose metabolism, Soliman et al. \[[@B11]\] suggest that among nondiabetic and diabetic individuals, IDA is associated with higher concentrations of HbA~1c~. Iron replacement therapy decreases HbA~1c~ in both diabetic and nondiabetic individuals. This implies that the iron states must be considered during the interpretation of HbA~1c~ concentrations in diabetic or nondiabetic patients. Early diagnosis and treatment of IDA in diabetic patients can improve their glycemic control and may prevent or delay complications.

Worldwide, over 40% of children have IDA, frequently associated with infections. Certain cytokines are involved in both immune activation of/response to infection and iron transport/metabolism. An increased susceptibility to infections has been reported in some IDA patients, the etiology of which is not well known \[[@B5]\].

Iron is required for monocyte/macrophage differentiation, while macrophages require iron as a cofactor for the execution of important antimicrobial effector mechanisms, including the nicotinamide adenine dinucleotide phosphate hydrogen-dependent oxidative burst \[[@B12]\].

Little is known concerning the effect of clinical iron deficiency on cytokines, although it has been reported that in vitro production of cytokines by lymphocytes in iron-deficient patients may be impaired \[[@B5]\] and thus may make people with IDA more susceptible to infections.

Conclusion {#sec1_4}
==========

IDA commonly presents with typical signs and symptoms. However, it rarely can present with atypical presentation, lymphocytopenia being one of them. There is a lack of clinical research regarding the effect of IDA on white blood cells. However, the clinician should pay attention to such a presentation as it can lead to infection because of lymphocytopenia.
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###### 

Complete blood count upon presentation

  Group                Detail                                   Date                      Value           Flags   Normal range   Comment Ind
  -------------------- ---------------------------------------- ------------------------- --------------- ------- -------------- -------------
  General hematology   WBC                                      03/12/2018 13:20:00 AST   7.5×10^3^/µL            4.0--10.0      
  General hematology   RBC                                      03/12/2018 13:20:00 AST   4.1×10^6^/µL            3.8--4.8       
  General hematology   Hgb                                      03/12/2018 13:20:00 AST   5.2 g/dL        CRIT    12.0--15.0     Y
  General hematology   Hct                                      03/12/2018 13:20:00 AST   21.2%           LOW     36.0--46.0     
  General hematology   MCV                                      03/12/2018 13:20:00 AST   51.2 fL         LOW     83.0--101.0    
  General hematology   MCH                                      03/12/2018 13:20:00 AST   12.6 pg         LOW     27.0--32.0     
  General hematology   Platelet                                 03/12/2018 13:20:00 AST   302×10^3^/µL            150--400       
  General hematology   Absolute neutrophil count auto\# (ANC)   03/12/2018 13:20:00 AST   6.19×10^3^/µL           2.00--7.00     
  General hematology   Lymphocyte auto\#                        03/12/2018 13:20:00 AST   0.74×10^3^/µL   LOW     1.00--3.00     

###### 

Iron profile ≫ severe iron deficiency anemia

  Group             Detail           Date                      Value         Flags   Normal range   Comment Ind
  ----------------- ---------------- ------------------------- ------------- ------- -------------- -------------
  Blood chemistry   Iron             07/08/2019 10:40:00 AST   5.23 µmol/L   LOW     5.90--18.30    
  Blood chemistry   TIBC             07/08/2019 10:40:00 AST   70 µmol/L             45--80         
  Blood chemistry   Fe% saturation   07/08/2019 10:40:00 AST   7%            LOW     15--45         
  Endocrinology     Ferritin         07/08/2019 10:40:00 AST   3 µg/L        LOW     6.0--44.0      

###### 

Vitamin B12, folate and thyroid function test

  Group           Detail     Date                      Value          Flags   Normal range   Comment
  --------------- ---------- ------------------------- -------------- ------- -------------- ---------
  Endocrinology   Vit. B12   15/09/2019 18:50:00 AST   250.0 pmol/L           145.0--596.0   
  Endocrinology   Folate     07/08/2019 10:40:00 AST   17.74 nmol/L   HIGH    2.70--16.30    
  Endocrinology   TSH        28/01/2019 08:32:00 AST   2.260 mIU/L            0.700--3.400   Y
  Endocrinology   fT~4~      28/01/2019 08:32:00 AST   10.7 pmol/L            7.9--13.6      Y

###### 

Laboratory results after therapy

  Group                Detail              Date                      Value           Flags   Normal range   Comment Ind
  -------------------- ------------------- ------------------------- --------------- ------- -------------- -------------
  General hematology   RBC                 07/08/2019 10:40:00 AST   5.0×10^6^/µL    HIGH    3.8--4.8       
  General hematology   RBC                 07/08/2019 10:40:00 AST   5.2×10^6^/µL    HIGH    3.8--4.8       
  General hematology   Hgb                 07/08/2019 10:40:00 AST   11.0 g/dL       LOW     12.0--15.0     
  General hematology   Platelet            07/08/2019 10:40:00 AST   408×10^3^/µL    HIGH    150--400       
  General hematology   Platelet            07/08/2019 10:40:00 AST   392×10^3^/µL            150--400       
  General hematology   Lymphocyte auto\#   07/08/2019 10:40:00 AST   1.41×10^3^/µL           1.00--3.00     
  Endocrinology        Ferritin            07/08/2019 10:40:00 AST   31.9 ng/L               6.0--44.0      
